Telecare for Patients with Type 1 Diabetes and Inadequate Glycemic Control
Response to Montori et al.
- Eberhard Biermann, MD,
- Norm Bogner,
- Julian Rihl, MD and
- Eberhard Standl, MD
- From the Institute for Diabetes Research, City Hospital Munich-Schwabing, Muenchen, Bavaria, Germany
- Address correspondence to Eberhard Biermann, MD, Institute for Diabetes Research, City Hospital Munich-Schwabing, Koelnerplatz 1, Muenchen, 80804, Germany. E-mail: eberhard.biermann{at}lrz.uni-muenchen.de
The insightful study of Montori et al. (1) raises the question of whether telecare can close the gap between the necessary and frequent interventions by health care professionals in order to lower the HbA1c of patients. We would like to comment on the control group and meta-analysis in their study.
Telecare can be embedded into different achievable scenarios, where the left-most cornerstone considers a control group and where conventional care means no intervention (A). The right-most cornerstone …
